ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1599 • ACR Convergence 2023

    Single-Cell RNA Sequencing Reveals Cellular Drivers of UV-mediated Skin Injury in Cutaneous Lupus

    Mitra Maz1, Feiyang Ma2, Mehrnaz Gharaee-Kermani2, Amanda Victory2, Amy Hurst2, Johann E. Gudjonsson2 and J. Michelle Kahlenberg2, 1University of Michigan Medical School, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: Ultraviolet light (UV) is a known trigger of cutaneous lupus erythematosus (CLE) flares in systemic lupus erythematosus (SLE) patients, yet cell populations and mechanisms…
  • Abstract Number: 1128 • ACR Convergence 2023

    Refractory Inflammatory Ocular Pathology and Treatment with Janus Kinase Inhibitors. Multicenter Study and Literature Review

    Carmen Lasa-Teja1, Lara Sanchez-Bilbao2, Jose Luis Martin-Varillas3, Vanesa Calvo Río4, José Luis Álvarez-Vega5, Emma Beltran-Catalan6, María del Mar Esteban-Ortega7, Santiago Muñoz7, Olga Maiz8, Ignacio Torre-Salaberri9, Ana Urruticoechea10, Elia Valls-Pascual11, Raúl Veroz12, Carmen Alvarez Reguera13, Rosalía Demetrio13 and Ricardo Blanco14, 1Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology Group, Santander, Spain, 2Hospital Universitario Marques de Valdecilla, Santander, Spain, 3Hospital de Laredo, Laredo, Spain, 4Valdecilla Hospital, Santander, Spain, 5Complejo Hospitalario Universitario de Badajoz, Badajoz, Spain, 6HOSPITAL DEL MAR, Barcelona, Spain, 7Hospital Infanta Sofia, Madrid, Spain, 8Hospital Universitario de Donostia. San Sebastián, Spain., Donosti, Spain, 9Hospital Universitario de Basurto, Bilbao, Spain, 10Hospital Can Misses, Ibiza, Spain, 11Hospital Universitario Doctor Peset. Alicante, Spain., Valencia, Spain, 12Hospital de Mérida, Mérida. Spain., Mérida, Spain, 13Hospital Universitario Marqués de Valdecilla, Santander, Spain, 14Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: Inflammatory ocular pathology (IOP) includes internal (uveitis) and external [mainly ocular surface pathology such as epi/scleritis and peripheral ulcerative keratitis (PUK)] involvement. IOP may…
  • Abstract Number: 1396 • ACR Convergence 2023

    Comprehensive Evaluation of the Digital Annular Pulleys: From Ultrasonographical to Anatomical and Histological Evaluation with Special Focus on the Entheses

    Luis Coronel1, Peter Mandl2, María Isabel Miguel3, Joan Blasi4, Maria Lopez-Lasanta1, Sara Marsal1, Maria-Antonietta D'Agostino5 and Ingrid Moller6, 1Hospital Universitari Vall d'Hebron, Rheumatology, Barcelona, Spain, 2Department of Rheumatology, Medical University of Vienna, Vienna, Austria, 3Universitat de Barcelona - Campus Bellvitge, Unitat d’anatomía i embriología humana, L'Hospitalet de Llobregat, Barcelona, Spain, 4Universitat de Barcelona - Campus Bellvitge, Histologia, L'Hospitalet de Llobregat, Barcelona, Spain, 5Universita Cattolica del Sacro Cuore Rome, Courbevoie, France, 6Instituto Poal de Reumatología, Barcelona, Spain

    Background/Purpose: The digital annular pulleys (DAP) are anatomical structures of soft connective tissue organized as transverse fibers of variable width, thickness, and configuration that overlay…
  • Abstract Number: 1519 • ACR Convergence 2023

    Renal Complications Following Autologous Stem Cell Transplantation for Systemic Sclerosis

    Malcolm MacKenzie1, Harry Atkins2 and Nancy Maltez1, 1The Ottawa Hospital, Ottawa, ON, Canada, 2Ottawa Hospital Research Institute, Ottawa, ON, Canada

    Background/Purpose: Rapidly progressive diffuse systemic sclerosis (SSc) is a devastating autoimmune disease with high morbidity and mortality. Autologous hematopoietic stem cell transplantation (AHSCT) is recognized…
  • Abstract Number: 1588 • ACR Convergence 2023

    Monocyte-derived Macrophages Accumulate in the Lungs in anti-MDA5+ Dermatomyositis with RP-ILD: Proinflammatory and Profibrotic Phenotype Revealed by Single-cell RNA Sequencing

    Xiaoya Pei1, Jia Shi2, Yangzhong Zhou2, Xiao Zhang2, Xiaoman Wang1, Mingwei Tang2, Shuang Zhou2, chanyuan wu2, Jinmin Peng3, Mengtao Li4, xiaofeng Zeng2, Jun Liu5, Houzao Chen1 and Qian Wang2, 1State Key Laboratory of Medical Molecular Biology, Department of Biochemistry and Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China, 2Department of Rheumatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 3Medical Intensive Care Unit, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China, 4Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 5State Key Laboratory of Protein and Plant Gene Research, School of Life Sciences, Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China

    Background/Purpose: Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (anti-MDA5+ DM) is a rare inflammatory autoimmune disease with impressively life-threatening rapid progressive interstitial lung disease (RP-ILD). The mechanism…
  • Abstract Number: 1585 • ACR Convergence 2023

    Defining Neutrophil-Mediated Renal Damage Triggered by Ultraviolet (UV) Skin Exposure

    Angelique Cortez1, Lindsay Mendyka2, Fred Kolling3, Michael Whitfield1 and Sladjana Skopelja-Gardner4, 1Dartmouth College, Hanover, NH, 2Dartmouth Hitchcock, Lebanon, NH, 3Geisel School of Medicine at Dartmouth, Hanover, NH, 4Dartmouth-Hitchcock, Lebanon, NH

    Background/Purpose: Lupus (SLE) is one of the leading causes of death in young women in the United States. Roughly ~80% of SLE patients experience sensitivity…
  • Abstract Number: 0391 • ACR Convergence 2023

    Biologic Use Regulates the Impact of Inflammation on Ischemic Cardiovascular Risk in Rheumatoid Arthritis

    George Karpouzas1, Sarah Ormseth2, Piet Van Riel3, Elena Myasoedova4, Miguel A Gonzalez-Gay5, Alfonso Corrales6, Solbritt Rantapää-Dahlqvist7, Petros Sfikakis8, Patrick Dessein9, Linda Tsang9, Carol Hitchon10, Hani El Gabalawi10, Virginia Pascual Ramos11, Irazú Contreras Yañez12, Iris Colunga13, Dionicio A. Galarza-Delgado13, José Ramón Azpiri-López13, Silvia Rolefstad14, Anne Grete Semb15, Durga P Misra16, Ellen Margrethe Hauge17 and GEORGE KITAS18, 1Harbor-UCLA Medical Center, Torrance, CA, 2The Lundquist Institute, Torrance, CA, 3Radboud University Medical Center, Drunen, Netherlands, 4Mayo Clinic, Rochester, MN, 5IDIVAL and School of Medicine, UC, Santander; Department of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid, Santander, Spain, 6Rheumatology Department, Immunopathology Group, Hospital Universitario Marqués de Valdecilla-IDIVAL, Santander, Spain, 7Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 8National Kapodistrian University of Athens Medical School, Athens, Greece, 9University of Witwatersrand, Johannesburg, South Africa, 10University of Manitoba, Winnipeg, MB, Canada, 11Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 12Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 13Hospital Universitario UANL, Monterrey, Mexico, 14Diakonhjemmet Hospital, Oslo, Norway,, Oslo, Norway, 15Preventive Cardio-Rheuma clinic, Dept Rheum, Diakonhjemmet Hospital, Oslo, Norway, 16Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India, 17Aarhus University Hospital, Aarhus, Denmark, 18The Dudley Group NHS Foundation Trust, Birmingham, United Kingdom

    Background/Purpose: Chronic inflammation contributes to enhanced cardiovascular risk in rheumatoid arthritis (RA). Biologic disease modifying antirheumatic drugs (bDMARDs) control inflammation in many conventional synthetic DMARD…
  • Abstract Number: 1596 • ACR Convergence 2023

    A Cell and Transcriptomic Atlas of the Infrapatellar Fat Pad from Patients with Knee Osteoarthritis: Identification of an Obesity-Associated Transcriptomic Signature

    Hayley Peters1, Pratibha Potla1, Jason Rockel1, Keemo Delos Santos1, Shabana Vohra1, starlee lively2, Kim Perry3, Anthony Perruccio1, Nizar Mahomed4, Raja Rampersaud1, Rajiv Gandhi5 and Mohit Kapoor6, 1Schroeder Arthritis Institute, Toronto, ON, Canada, 2University Health Network, Toronto, ON, Canada, 3Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 4Division of Orthopaedics, Osteoarthritis Research Program, Schroeder Arthritis Institute, Krembil Research Institute, and Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 5Schroeder Arthritis Institute, Krembil Research Institute, University Health Network and Division of Orthopaedics, Department of Surgery, University of Toronto, Toronto, ON, Canada, 6Schroeder Arthritis Institute, University Health Network and Department of Surgery, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Knee osteoarthritis (KOA) is the most common form of arthritis that affects multiple knee joint tissues. The infrapatellar fat pad is the largest fat…
  • Abstract Number: 0988 • ACR Convergence 2023

    Elderly Patients’ Discontinuation of Biologic DMARDs in Patients with Rheumatic Diseases: Data from the Mexican Adverse Events Registry (BIOBADAMEX)

    Vijaya Rivera Terán1, David Vega Morales2, Miguel Angel Saavedra Salinas3, Daniel Xavier Xibillé Friedman4, Iris Colunga5, Sandra Carrillo Vazquez6, Dafhne Miranda Hernández7, Sergio Durán Barragán8, Erick Adrián Zamora Tehozol9, Angel Alejandro Castillo Ortiz10, Sandra Sicsik Ayala11, Fedra Irazoque Palazuelos6, Julio César Casasola Vargas12, Angelica Peña13, Omar Eloy Muñoz Monroy14, Azucena Ramos Sánchez2, Luis Valdés Corona15, Javier Merayo-Chalico16, Estefania Torres Valdez13, Aleni Paz Viscarra15 and Deshiré Alpízar Rodríguez1, 1Colegio Mexicano de Reumatología, Mexico City, Mexico, 2Instituto Mexicano del Seguro Social, Monterrey, Mexico, 3IMSS, Mexico City, Mexico, 4Práctica Privada, Cuernavaca, Mexico, 5Hospital Universitario UANL, Monterrey, Mexico, 6Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mexico City, Mexico, 7Instituto Mexicano del Seguro Social, Mexico City, Mexico, 8Consulta Privada, Guadalajara, Mexico, 9Centro Médico Pensiones, Mérida, Mexico, 10Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado, Mérida, Mexico, 11Instituto Mexicano del Seguro Social, Torreón, Mexico, 12Instituto de Seguridad Social del Estado de México y Municipios, Mexico City, Mexico, 13Instituto Mexicano del Seguro Social, Querétaro, Mexico, 14Hospital Central Militar, Mexico City, Mexico, 15Práctica Privada, Mexico City, Mexico, 16Reumátika, Centro de Vanguardia en Reumatología de la Ciudad de México, Mexico City, Mexico

    Background/Purpose: The approach to elderly patients (≥60 years) with rheumatic diseases offers certain difficulties and uncertainties. Older adults are a particularly vulnerable group who often…
  • Abstract Number: 0942 • ACR Convergence 2023

    G Protein-coupled Receptor Kinase 5 in Fibrotic Tissue Remodeling

    Cuong Tran-Manh1, Thuong Trinh-Minh1, Christoph Liebel1, Chih-Wei Chen2 and Joerg Distler1, 1Clinic for Rheumatology University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany; Hiller Research Center, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Düsseldorf, Germany, 23 Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and University Hospital Erlangen, Erlangen, Germany. 4 Deutsches Zentrum für Immuntherapie, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany., Erlangen, Germany

    Background/Purpose: G-protein coupled receptor kinase 5, GRK5, is a central regulator of G protein-coupled receptors (GPCRs), a vast family of cell surface receptors involved in…
  • Abstract Number: 1137 • ACR Convergence 2023

    Association Between Nailfold Videocapillaroscopy Findings and sKL-6 Levels in Patients with Idiopathic Inflammatory Myopathies–Related Interstitial Lung Disease

    Cristiana Sieiro Santos1, Jose Luis Tandaipan2, Diego Castillo2, Laura Martínez Martínez2, Helena Codes2, Luis Sainz-Comas2, Berta Paula Magallares-Lopez3, Patricia Moya2, Anais Mariscal2, Hye Sang Park2, Ana Milena Millán Arciniegas2, César Díaz-Torné2, Ana Laíz Alonso2, Sandra Ros2, Susana Fernández2, Hector Corominas4, Elvira Díez Álvarez5 and Iván Castellvi2, 1Complejo Asistencial Universitario de León, León, Spain, 2Hospital de Santa Creu i Sant Pau, Barcelona, Spain, 3Department of Rheumatology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain, 4Hospital Universitario Sant Pau, Rheumatology, Barcelona, Spain, 5CAULE, León, Spain

    Background/Purpose: Interstitial lung disease (ILD) is a frequent pulmonary manifestation in idiopathic inflammatory myopathies (IIM) (IIM-ILD) and considerably influences morbidity and mortality. Krebs von den…
  • Abstract Number: 1590 • ACR Convergence 2023

    Autoimmune Pathway Blockade by a Potent Orally Bioavailable STING Antagonist

    Min Yang1, Hailong Li1, yangyang liu1, lili yao1, Jing Lin1, Zhi xie2 and Wenge zhong1, 1Regor Therapeutics, Shanghai, China, 2Regor Pharmaceuticals, Inc., San Francisco, CA

    Background/Purpose: The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway has emerged as a key innate immune mediator of autoimmune and inflammatory diseases. However,…
  • Abstract Number: 1525 • ACR Convergence 2023

    Chelation Therapy in the Management of Calcinosis Associated with Systemic Sclerosis

    Alison Fernandes, Ashraf El-Meanawy and ME Csuka, Medical College of Wisconsin, Milwaukee, WI

    Background/Purpose: Calcinosis is a common complication of systemic sclerosis (SSc), though effective treatment options are limited. Of the several medical therapies that have been employed…
  • Abstract Number: 1398 • ACR Convergence 2023

    A Deep Learning Algorithm for MRI Spinal Inflammation in Axial Spondyloarthritis

    Shirley Chiu Wai Chan1, Ying Ying Lin2, Ho Yin Chung1, Kam Ho Lee3 and Peng Cao2, 1Divison of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, the University of Hong Kong, Hong Kong, Hong Kong, 2Department of Diagnostic Radiology, the University of Hong Kong, Hong Kong, Hong Kong, 3Department of Radiology, Queen Mary Hospital, Hong Kong, Hong Kong, Hong Kong

    Background/Purpose: Deep learning has achieved wide applications in different areas of medical imaging analysis. Limited studies have explored the use of deep learning for imaging…
  • Abstract Number: 1148 • ACR Convergence 2023

    A Comparative Study of Clinical Phenotype in Relation to NOD2 Sub-genotypes in Yao Syndrome

    Ashmia Saif1, Hafsa Nomani2, Frank Hwang2, Jie Yang2 and Qingping Yao2, 1Stony Brook University Hospital, Syosset, NY, 2Stony Brook University, Stony Brook, NY

    Background/Purpose: Yao syndrome (YAOS, OMIM 617321) is formerly designated NOD2-associated autoinflammatory disease. A spectrum of NOD2 mutations have been associated with this disease. Most patients…
  • « Previous Page
  • 1
  • …
  • 269
  • 270
  • 271
  • 272
  • 273
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology